Fairmount Funds Management LLC, Director purchased 525,897 shares of CRESCENT BIOPHARMA, INC. ($CBIO) @ $14.50 ($7,624,980.60 total) on Jul 16, 2026

Jul 16, 2026

52W Low$8.72

Current$15.0533.9% above low, 66.1% below high

Purchase$14.5030.9% above low, 69.1% below high

52W High$27.41

525,897

Price

$14.50

Total Value

$7,624,980.60

P&L

+3.8% (+$289,769.25)

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Fairmount Funds Management LLC
Title	Director
Transaction Date	Jul 16, 2026
Transaction Code	P Purchase
Acquired/Disposed	Acquired
Security	Pre-Funded Warrant (Right to Buy) (Ordinary Shares)
Derivative	Yes
Direct/Indirect	Indirect
Nature of Ownership	By Fairmount Healthcare Fund II L.P.
Filing Date	Jul 20, 2026
Shares Purchased	525,897
Price per Share	$14.50
Total Value	$7,624,980.60
Shares Owned After	2,294,037
Derivative	Derivative (Ordinary Shares)
Accession Number	0001104659-26-085113
Document	View SEC Filing